Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 9k
7 November 2019
E-003686/2019/rev.1
Question for written answer
to the Commission
Rule 138
Petra De Sutter
 Subject: Importance of brain research in Horizon Europe

Brain disorders affect over 160 million European citizens and weigh heavily on EU healthcare systems. According to calculations for the European Brain Council, healthcare costs for mental and neurological conditions amount to more than 4 % of the EU’s gross domestic product. To tackle this brain health emergency, Europe must massively invest in brain research and ensure that novel scientific insights are developed and implemented faster.

However, the Commission does not seem to recognise the sense of urgency of brain research, as it remains largely underfunded and is not at all considered a priority in the strategic plan for Horizon Europe. In early September, researchers from 30 leading institutions and patient organisations reached out to DG Research and Innovation, calling for an increased emphasis on brain health in the strategic plan for Horizon Europe, but they have yet to receive an answer to their letter.

Will the Commission respond to the researchers’ call for action and recognise the importance of brain research in Europe?

What will it do to tackle the brain health emergency in Europe?

Will more attention be given to brain research in Horizon Europe, in particular by increasing funding in this area?

Last updated: 3 December 2019Legal notice